Evaluation of Brain Perfusion and Oxygenation in PD Patients With Neurogenic Orthostatic Hypotension: 4 Week Comparison of Droxidopa Versus Placebo
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2018
At a glance
- Drugs Droxidopa (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
- 20 Jul 2018 Planned End Date changed from 1 Sep 2018 to 1 Aug 2019.
- 20 Jul 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Aug 2019.
- 20 Jul 2018 Status changed from not yet recruiting to recruiting.